首页 > 市场调查报告书 > 医疗设备

生技设备

市场调查报告书

商品编码

1705631

全球多重分析市场按产品、类型、技术、应用、最终用户和地区划分

Global Multiplex Assay Market, By Product, By Type, By Technology, By Application, By End User, By Geography

出版日期: 2025年03月04日 | 出版商:

Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年全球多重检测市场规模为 17 亿美元，到 2032 年将达到 44.5 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 14.7%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	17亿美元
效能数据	从2020年到2024年	预测期	2025年至2032年
预测期：2025-2032年复合年增长率：	14.70%	2032年价值预测	44.5亿美元

数字。 2025年全球市场占有率（%）

近年来，受全球慢性病和感染疾病率上升的推动，多重检测市场经历了显着增长。多重分析允许在单次分析中同时检测多种分析物，从而提高诊断准确性和吞吐量。这使得实验室能够简化测试流程，同时最大限度地降低营运成本。包括微阵列和以微珠为基础的技术在内的各种技术进步促进了高通量多路復用平台的开发，该平台具有高灵敏度和特异性，可用于临床诊断和研究应用。展望未来，易患与老龄化相关的疾病的老年人口的增加、诊断测试的医疗支出的增加以及精准医疗的扩展预计将为多重检测市场中的公司提供丰厚的机会。

市场动态：

多重检测市场受到个人化医疗需求不断增长、蛋白质组学和基因组学领域研发活动强劲以及多重检测在生物标记研究和临床诊断中的应用不断扩大等因素的推动。然而，复杂的检测开发和严格的法律规范带来了限制市场成长的挑战。微射流和数位 PCR 技术的发展促进了高通量、低样本量、可携式多路復用平台的开发，创造了新的机会。缺乏熟练的专业人才和高成本也在一定程度上对市场扩张构成挑战。

多重检测技术的日益普及是市场发展的关键驱动力。多重分析允许在单一实验中同时分析多个目标，因此与传统的单重分析相比具有许多优势。多重分析具有透过多种方式推动市场成长的潜力，包括能够同时测试多种分析物，从而节省实施的时间和精力。透过整合测试，多重检测可以降低与试剂、消耗品和实验室开销相关的整体成本。多重分析非常适合高通量筛检，并且可用于大规模研究和临床诊断。多路復用技术可以分析有限的样本量，从而保存切片检查和稀有细胞群等珍贵样本。

例如，2021 年 6 月，食品、环境、药品和化妆品检测领域的全球领导者 Eurofins 宣布推出 GSD NovaType III SARS-CoV-2 RT-PCR 检测，该检测旨在快速检测 SARS-CoV-2 变体。此检测可在单一反应中识别相关突变 E484Q、E484K 和 L452R，同时便于将它们与 S 基因 E484 野生型变异区区分开来。

研究的主要特点

本报告对全球多重检测市场进行了详细分析，并以 2024 年为基准年，展示了预测期（2025-2032 年）的市场规模和年复合成长率（CAGR%）。
它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的主要考察。
该报告根据公司亮点、产品系列、关键亮点、财务表现和策略等参数，概述了全球多重检测市场的主要企业。
本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
全球多重分析市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
相关人员将透过用于分析全球多重分析市场的各种策略矩阵来做出决策。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 1.7 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	14.70%	2032 Value Projection:	USD 4.45 Bn

The multiplex assay market has been witnessing significant growth in the recent past on account of the rising incidence of chronic and infectious diseases globally. Multiplexing permits simultaneous detection of multiple analytes in a single assay run, which enhances diagnostic accuracy and throughput. It allows laboratories to streamline testing processes while minimizing operational costs. Various technological advancements including microarrays and bead-based techniques have facilitated the development of high-throughput multiplex platforms with high sensitivity and specificity for clinical diagnostics and research applications. Going forward, the growing geriatric population vulnerable to age-related illnesses, increasing healthcare expenditures on diagnostic testing, and expansion of precision medicine are expected to present lucrative opportunities for players in the multiplex assay market.

Market Dynamics:

The multiplex assay market is driven by factors such as growing demand for personalized medicine, robust R&D activity in the field of proteomics and genomics, and increasing applications of multiplex assays in biomarker research and clinical diagnostics. However, complexity of assay development and stringent regulatory framework are some challenges restraining the market growth. Adoption of microfluidics and digital PCR technologies create new opportunities by facilitating development of high-throughput, low sample volume, and portable multiplex platforms. Lack of skilled experts and high cost of instruments also challenge market expansion to some extent.

The growing adoption of multiplex assay techniques is a significant driver for the market. Multiplex assays offer numerous advantages over traditional singleplex assays by allowing the simultaneous analysis of multiple targets in a single experiment, which can drive the market growth in several ways such as multiplex assays can test for multiple analytes at once, saving time and labor compared to running. By consolidating tests, multiplex assays can reduce overall costs associated with reagents and consumables, as well as laboratory overhead. They are ideal for high-throughput screening, making them valuable in large-scale studies and clinical diagnostics. Multiplexing enables analysis from limited sample volumes, preserving precious samples like biopsy material or rare populations of cells.

For instance, in June 2021, Eurofins, the global leader in food, environment, pharmaceutical, and cosmetic product testing, announced the launch of GSD NovaType III SARS-CoV-2 RT-PCR assay, developed for the rapid detection of SARS-CoV-2 variants. The assay facilitates the identification of the relevant mutations E484Q, E484K, and L452R in one reaction combined with the simultaneous discrimination from the S gene E484 wildtype variant.

Key Features of the Study:

This report provides an in-depth analysis of the global multiplex assay market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global multiplex assay market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Luminex Corporation, Thermo Fisher Scientific, Inc., Illumina, Inc., Bio-Rad Laboratories, Inc., Qiagen, Abcam Plc., Becton, Dickinson and Company, Merck KGaA, Agilent Technologies, MESO SCALE DIAGNOSTICS, LLC., Randox Laboratories Ltd., Seegene Inc, Perkin Elmer Inc., R&D Systems, Inc., and Advanced Cell Diagnostics, Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global multiplex assay market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global multiplex assay market

Detailed Segmentation:

By Product
- Consumables
- Instruments
- Software
By Type
- Protein Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Nucleic Acid Multiplex Assays
- Planar Protein Assays
- Bead-based Protein Assays
- Cell-based Multiplex Assays
By Technology
- Flow Cytometry
- Fluorescence Detection
- Luminescence
- Multiplex Real-time PCR
- Other Technologies
By Application
- Research & Development
- Drug Discovery & Development
- Biomarker Discovery & Validation
- Clinical Diagnostics
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Autoimmune Diseases
- Nervous System Disorders
- Metabolism & Endocrinology Disorders
- Other Diseases
By End User
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostic laboratories
- Research & Academic Institutes
- Other End Users
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles
- Luminex Corporation
- Thermo Fisher Scientific, Inc.
- Illumina, Inc.
- Bio-Rad Laboratories, Inc.
- Qiagen
- Abcam Plc.
- Becton, Dickinson and Company
- Merck KGaA
- Agilent Technologies
- MESO SCALE DIAGNOSTICS, LLC.
- Randox Laboratories Ltd.
- Seegene Inc
- Perkin Elmer Inc.
- R&D Systems, Inc.
- Advanced Cell Diagnostics, Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Multiplex Assay Market, By Product
- Multiplex Assay Market, By Type
- Multiplex Assay Market, By Technology
- Multiplex Assay Market, By Application
- Multiplex Assay Market, By End User
- Multiplex Assay Market, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
- Advancing genomics and proteomics research
- Increasing focus on precision medicine
- Increasing product launches
Restraints
Opportunity
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Global Multiplex Assay Market, By Product, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Instruments
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

6. Global Multiplex Assay Market, By Type, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Protein Multiplex Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Planar Protein Assays
Bead-based Protein Assays
Nucleic Acid Multiplex Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Planar Protein Assays
Bead-based Protein Assays
Cell-based Multiplex Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

7. Global Multiplex Assay Market, By Technology, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Flow Cytometry
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Fluorescence Detection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Luminescence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Multiplex Real-time PCR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

8. Global Multiplex Assay Market, By Application, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Research & Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Drug Discovery & Development
Biomarker Discovery & Validation
Clinical Diagnostics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Infectious Diseases
Cancer
Cardiovascular Diseases
Autoimmune Diseases
Nervous System Disorders
Metabolism & Endocrinology Disorders
Other Diseases

9. Global Multiplex Assay Market, By End User, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021-2032
- Segment Trends
Pharmaceutical & Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Hospitals & Diagnostic laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)
Other End Users
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Bn)

10. Global Multiplex Assay Market, By Region, 2020-2032, (US$ Bn)

Introduction
- Market Share Analysis, By Country, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Bn)
  - U.S.
  - Canada
Europe
Asia Pacific
Latin America
Middle East
Africa

11. Competitive Landscape

Luminex Corporation
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Thermo Fisher Scientific, Inc.
Illumina, Inc.
Bio-Rad Laboratories, Inc.
Qiagen
Abcam Plc.
Becton, Dickinson and Company
Merck KGaA
Agilent Technologies
MESO SCALE DIAGNOSTICS, LLC.
Randox Laboratories Ltd.
Seegene Inc
Perkin Elmer Inc.
R&D Systems, Inc.
Advanced Cell Diagnostics, Inc.
Analyst Views

12. Section

Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

全球多重分析市场按产品、类型、技术、应用、最终用户和地区划分